Back to News
Market Impact: 0.2
IMUNON Announces Strategic Sale of ThermoDox®
Source: globenewswire.com
Healthcare & BiotechCompany Fundamentals
VoxelDox Therapeutics, Inc. has entered an agreement described as creating a path to future value, contingent on achieving development milestones. The planned Phase 1 trial will evaluate a treatment for glioblastoma; the headline provides no financial terms or trial timing.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- The U.S. market has never been more focused on one single bet—but AI’s payoff will likely take decades
- Meta put out an ambitious roadmap to Muse monetization after strong quarter and guide
- CoreWeave’s market confidence erodes as bond yields spike and stock sinks
- Why is Tesla stock falling after-hours today?
- Meta ordered to pay $25 billion in case related to Cambridge Analytica scandal
- Zuckerberg told Meta directors he might leave California, where he could lose billions to a wealth tax. Meta answered with a new class of stock